Association of peridialytic, intradialytic, scheduled interdialytic and ambulatory BP recordings with cardiovascular events in hemodialysis patients.


Journal

Journal of nephrology
ISSN: 1724-6059
Titre abrégé: J Nephrol
Pays: Italy
ID NLM: 9012268

Informations de publication

Date de publication:
04 2022
Historique:
received: 26 07 2021
accepted: 08 11 2021
pubmed: 7 1 2022
medline: 13 4 2022
entrez: 6 1 2022
Statut: ppublish

Résumé

Ambulatory-BP-monitoring (ABPM) is recommended for hypertension diagnosis and management in hemodialysis patients due to its strong association with outcomes. Intradialytic and scheduled interdialytic BP recordings show agreement with ambulatory BP. This study assesses in parallel the association of pre-dialysis, intradialytic, scheduled interdialytic and ambulatory BP recordings with cardiovascular events. We prospectively followed 242 hemodialysis patients with valid 48-h ABPMs for a median of 45.7 months to examine the association of pre-dialysis, intradialytic, intradialytic plus pre/post-dialysis readings, scheduled interdialytic BP, and 44-h ambulatory BP with outcomes. The primary end-point was a composite one, composed of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, resuscitation after cardiac arrest, hospitalization for heart failure, coronary revascularization procedure or peripheral revascularization procedure. Cumulative freedom from the primary end-point was significantly lower with increasing 44-h SBP (group 1, < 120 mmHg, 64.2%; group 2, ≥ 120 to < 130 mmHg 60.4%, group 3, ≥ 130 to < 140 mmHg 45.3%; group 4, ≥ 140 mmHg 45.5%; logrank-p = 0.016). Similar were the results for intradialytic (logrank-p = 0.039), intradialytic plus pre/post-dialysis (logrank-p = 0.044), and scheduled interdialytic SBP (logrank-p = 0.030), but not for pre-dialysis SBP (logrank-p = 0.570). Considering group 1 as the reference group, the hazard ratios of the primary end-point showed a gradual increase with higher BP levels with all BP metrics, except pre-dialysis SBP. This pattern was confirmed in adjusted analyses. An inverse association of DBP levels with outcomes was shown with all BP metrics, which was no longer evident in adjusted analyses. Averaged intradialytic and scheduled home BP measurements (but not pre-dialysis readings) display similar prognostic associations with 44-h ambulatory BP in hemodialysis patients and represent valid metrics for hypertension management in these individuals.

Sections du résumé

BACKGROUND
Ambulatory-BP-monitoring (ABPM) is recommended for hypertension diagnosis and management in hemodialysis patients due to its strong association with outcomes. Intradialytic and scheduled interdialytic BP recordings show agreement with ambulatory BP. This study assesses in parallel the association of pre-dialysis, intradialytic, scheduled interdialytic and ambulatory BP recordings with cardiovascular events.
METHODS
We prospectively followed 242 hemodialysis patients with valid 48-h ABPMs for a median of 45.7 months to examine the association of pre-dialysis, intradialytic, intradialytic plus pre/post-dialysis readings, scheduled interdialytic BP, and 44-h ambulatory BP with outcomes. The primary end-point was a composite one, composed of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, resuscitation after cardiac arrest, hospitalization for heart failure, coronary revascularization procedure or peripheral revascularization procedure.
RESULTS
Cumulative freedom from the primary end-point was significantly lower with increasing 44-h SBP (group 1, < 120 mmHg, 64.2%; group 2, ≥ 120 to < 130 mmHg 60.4%, group 3, ≥ 130 to < 140 mmHg 45.3%; group 4, ≥ 140 mmHg 45.5%; logrank-p = 0.016). Similar were the results for intradialytic (logrank-p = 0.039), intradialytic plus pre/post-dialysis (logrank-p = 0.044), and scheduled interdialytic SBP (logrank-p = 0.030), but not for pre-dialysis SBP (logrank-p = 0.570). Considering group 1 as the reference group, the hazard ratios of the primary end-point showed a gradual increase with higher BP levels with all BP metrics, except pre-dialysis SBP. This pattern was confirmed in adjusted analyses. An inverse association of DBP levels with outcomes was shown with all BP metrics, which was no longer evident in adjusted analyses.
CONCLUSIONS
Averaged intradialytic and scheduled home BP measurements (but not pre-dialysis readings) display similar prognostic associations with 44-h ambulatory BP in hemodialysis patients and represent valid metrics for hypertension management in these individuals.

Identifiants

pubmed: 34988941
doi: 10.1007/s40620-021-01205-9
pii: 10.1007/s40620-021-01205-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

943-954

Informations de copyright

© 2021. The Author(s) under exclusive licence to Italian Society of Nephrology.

Références

Sarafidis PA, Persu A, Agarwal R et al (2017) Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). Nephrol Dial Transplant 32:620–640. https://doi.org/10.1093/ndt/gfw433
doi: 10.1093/ndt/gfw433 pubmed: 28340239
United States Renal Data System (2020) USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
Sarafidis PA, Mallamaci F, Loutradis C et al (2018) Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA. Nephrol Dial Transplant 33:1872. https://doi.org/10.1093/ndt/gfy263
doi: 10.1093/ndt/gfy263 pubmed: 30113666
(2005) K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45:S1–153
Foley RN, Herzog CA, Collins AJ, United States Renal Data System (2002) Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int 62:1784–1790. https://doi.org/10.1046/j.1523-1755.2002.00636.x
doi: 10.1046/j.1523-1755.2002.00636.x pubmed: 12371980
Robinson BM, Tong L, Zhang J et al (2012) Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 82:570–580. https://doi.org/10.1038/ki.2012.136
doi: 10.1038/ki.2012.136 pubmed: 22718187 pmcid: 3891306
Kovesdy CP, Bleyer AJ, Molnar MZ et al (2013) Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med 159:233–242. https://doi.org/10.7326/0003-4819-159-4-201308200-00004
doi: 10.7326/0003-4819-159-4-201308200-00004 pubmed: 24026256 pmcid: 4155539
Agarwal R, Metiku T, Tegegne GG et al (2008) Diagnosing hypertension by intradialytic blood pressure recordings. Clin J Am Soc Nephrol 3:1364–1372. https://doi.org/10.2215/CJN.01510308
doi: 10.2215/CJN.01510308 pubmed: 18495949 pmcid: 2518788
Zoccali C, Tripepi R, Torino C et al (2015) Moderator’s view: ambulatory blood pressure monitoring and home blood pressure for the prognosis, diagnosis and treatment of hypertension in dialysis patients. Nephrol Dial Transplant 30:1443–1448. https://doi.org/10.1093/ndt/gfv241
doi: 10.1093/ndt/gfv241 pubmed: 26022727
Karpetas A, Sarafidis PA, Georgianos PI et al (2015) Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis. Clin J Am Soc Nephrol 10:630–638. https://doi.org/10.2215/CJN.08180814
doi: 10.2215/CJN.08180814 pubmed: 25635033 pmcid: 4386257
Flythe JE, Chang TI, Gallagher MP et al (2020) Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 97:861–876. https://doi.org/10.1016/j.kint.2020.01.046
doi: 10.1016/j.kint.2020.01.046 pubmed: 32278617 pmcid: 7215236
Agarwal R, Brim NJ, Mahenthiran J et al (2006) Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension 47:62–68. https://doi.org/10.1161/01.HYP.0000196279.29758.f4
doi: 10.1161/01.HYP.0000196279.29758.f4 pubmed: 16344376
Agarwal R (2010) Blood pressure and mortality among hemodialysis patients. Hypertension 55:762–768. https://doi.org/10.1161/HYPERTENSIONAHA.109.144899
doi: 10.1161/HYPERTENSIONAHA.109.144899 pubmed: 20083728
Parati G, Ochoa JE, Bilo G et al (2016) Hypertension in chronic kidney disease part 1: out-of-office blood pressure monitoring: methods, thresholds, and patterns. Hypertension 67:1093–1101. https://doi.org/10.1161/HYPERTENSIONAHA.115.06895
doi: 10.1161/HYPERTENSIONAHA.115.06895 pubmed: 27141058
Karpetas A, Loutradis C, Bikos A et al (2017) Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients. J Hypertens 35:2517–2526. https://doi.org/10.1097/HJH.0000000000001478
doi: 10.1097/HJH.0000000000001478 pubmed: 28806350
Alexandrou ME, Loutradis C, Schoina M et al (2020) Ambulatory blood pressure profile and blood pressure variability in peritoneal dialysis compared with hemodialysis and chronic kidney disease patients. Hypertens Res 43:903–913. https://doi.org/10.1038/s41440-020-0442-0
doi: 10.1038/s41440-020-0442-0 pubmed: 32327730
Sarafidis PA, Loutradis C, Karpetas A et al (2019) The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients. Nephrol Dial Transplant 34:515–523. https://doi.org/10.1093/ndt/gfy247
doi: 10.1093/ndt/gfy247 pubmed: 30184172
Agarwal R, Andersen MJ, Bishu K, Saha C (2006) Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int 69:900–906. https://doi.org/10.1038/sj.ki.5000145
doi: 10.1038/sj.ki.5000145 pubmed: 16518349
Parati G, Ochoa JE, Bilo G et al (2016) Hypertension in chronic kidney disease part 2: role of ambulatory and home blood pressure monitoring for assessing alterations in blood pressure variability and blood pressure profiles. Hypertension 67:1102–1110. https://doi.org/10.1161/HYPERTENSIONAHA.115.06896
doi: 10.1161/HYPERTENSIONAHA.115.06896 pubmed: 27141057
Sarafidis P, Theodorakopoulou MP, Loutradis C, Iatridi F, Alexandrou M-E, Karpetas A, Koutroumpas G, Raptis V, Ferro CJ, Papagianni A (2021) Accuracy of peridialytic, intradialytic, and scheduled interdialytic recordings in detecting elevated ambulatory blood pressure in hemodialysis patients. Am J Kidney Dis 78(5):630–639.e1. https://doi.org/10.1053/j.ajkd.2021.01.022
doi: 10.1053/j.ajkd.2021.01.022 pubmed: 33857534
Wei W, Tölle M, Zidek W, van der Giet M (2010) Validation of the mobil-O-Graph: 24 h-blood pressure measurement device. Blood Press Monit 15:225–228. https://doi.org/10.1097/MBP.0b013e328338892f
doi: 10.1097/MBP.0b013e328338892f pubmed: 20216407
Sarafidis PA, Lazaridis AA, Imprialos KP et al (2016) A comparison study of brachial blood pressure recorded with Spacelabs 90217A and Mobil-O-Graph NG devices under static and ambulatory conditions. J Hum Hypertens 30:742–749. https://doi.org/10.1038/jhh.2016.11
doi: 10.1038/jhh.2016.11 pubmed: 26935286
Agarwal R, Peixoto AJ, Santos SFF, Zoccali C (2006) Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 1:389–398. https://doi.org/10.2215/CJN.01891105
doi: 10.2215/CJN.01891105 pubmed: 17699236
Sarafidis PA, Mallamaci F, Loutradis C et al (2019) Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA. Nephrol Dial Transplant 34:1542–1548. https://doi.org/10.1093/ndt/gfy147
doi: 10.1093/ndt/gfy147 pubmed: 30007295
Bikos A, Angeloudi E, Memmos E et al (2018) A comparative study of short-term blood pressure variability in hemodialysis patients with and without intradialytic hypertension. Am J Nephrol 48:295–305. https://doi.org/10.1159/000493989
doi: 10.1159/000493989 pubmed: 30347395
Alborzi P, Patel N, Agarwal R (2007) Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol 2:1228–1234. https://doi.org/10.2215/CJN.02250507
doi: 10.2215/CJN.02250507 pubmed: 17942773
Sarafidis PA, Loutradis C, Karpetas A et al (2017) Ambulatory pulse wave velocity is a stronger predictor of cardiovascular events and all-cause mortality than office and ambulatory blood pressure in hemodialysis patients. Hypertension 70:148–157. https://doi.org/10.1161/HYPERTENSIONAHA.117.09023
doi: 10.1161/HYPERTENSIONAHA.117.09023 pubmed: 28483919
Mayer CC, Matschkal J, Sarafidis PA et al (2018) Association of ambulatory blood pressure with all-cause and cardiovascular mortality in hemodialysis patients: effects of heart failure and atrial fibrillation. J Am Soc Nephrol 29:2409–2417. https://doi.org/10.1681/ASN.2018010086
doi: 10.1681/ASN.2018010086 pubmed: 30045925 pmcid: 6115666
Kannel WB, Wilson PWF, Nam B-H et al (2004) A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol 94:380–384. https://doi.org/10.1016/j.amjcard.2004.04.043
doi: 10.1016/j.amjcard.2004.04.043 pubmed: 15276113
Sarafidis PA, Loutradis C, Mayer CC et al (2019) Weak within-individual association of blood pressure and pulse wave velocity in hemodialysis is related to adverse outcomes. J Hypertens 37:2200–2208. https://doi.org/10.1097/HJH.0000000000002153
doi: 10.1097/HJH.0000000000002153 pubmed: 31584899
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group (2021) KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 99:S1–S87. https://doi.org/10.1016/j.kint.2020.11.003
doi: 10.1016/j.kint.2020.11.003
Parati G, Stergiou GS, Asmar R et al (2010) European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens 24:779–785. https://doi.org/10.1038/jhh.2010.54
doi: 10.1038/jhh.2010.54 pubmed: 20520631
Parati G, Stergiou G, O’Brien E et al (2014) European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 32:1359–1366. https://doi.org/10.1097/HJH.0000000000000221
doi: 10.1097/HJH.0000000000000221 pubmed: 24886823

Auteurs

Fotini Iatridi (F)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.

Marieta P Theodorakopoulou (MP)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.

Antonios Karpetas (A)

Therapeutiki Hemodialysis Unit, Thessaloniki, Greece.

Athanasios Bikos (A)

Protypo Hemodialysis Unit, Thessaloniki, Greece.

Artemios G Karagiannidis (AG)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.

Maria-Eleni Alexandrou (ME)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.

Ioannis Tsouchnikas (I)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.

Christopher C Mayer (CC)

Center for Health and Bioresources, Biomedical Systems, Austrian Institute of Technology, Vienna, Austria.

Anna-Bettina Haidich (AB)

Department of Hygiene, Social-Preventative Medicine and Medical Statistics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Aikaterini Papagianni (A)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642, Thessaloniki, Greece.

Gianfranco Parati (G)

Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, IRCCS, Istituto Auxologico Italiano, Milan, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Pantelis A Sarafidis (PA)

Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642, Thessaloniki, Greece. psarafidis11@yahoo.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH